Evaluation of pregabalin-induced adverse events related to falls using the FDA adverse event reporting system and Japanese Adverse Drug Event Report databases.


WHAT IS KNOWN AND OBJECTIVE:Pregabalin is used for neuropathic and postherpetic pain and generalized anxiety. The aim of this study was to obtain the onset profiles of adverse events (AE) related to falls (AEFs) such as "somnolence," "dizziness," "loss of consciousness" and "fall" onset and several clinical factor combinations such as age and administered dose, using spontaneous reporting system (SRS) analysis such as the US Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database. METHODS:We used the reporting odds ratio (ROR) to analyse the association between pregabalin and AEFs. Additionally, we used the time-to-onset analysis. RESULTS AND DISCUSSION:The crude RORs of AEFs such as somnolence and dizziness were higher than one for both the databases. The adjusted RORs for AEFs in the ≥60 years age group compared to those in the <60 years age group for the FAERS and JADER databases were 1.46 (95% CI = 1.39-1.53; P < 0.0001) and 2.58 (95% CI = 2.06-3.27; P < 0.0001), respectively. In the JADER database, the median and quartile range for AEFs with pregabalin, at ≤75 and ≥100 mg/d, were 2.0 (0.0-5.0) and 2.0 (1.0-4.3) days, respectively. Additionally, 57.2% of AEFs (four preferred terms) were observed within 2 days after administration. WHAT IS NEW AND CONCLUSIONS:This study is the first to evaluate the relationship between pregabalin and AEFs using the SRS analysis strategy. The risk of AEFs in the ≥60 years age group might increase compared to that in the <60 years age group. AEFs occurred almost within 1 week after pregabalin administration, and the median for AEF onset was 2 days. Our results show that patients should be closely monitored for AEFs for 1 week from the start of pregabalin administration.


J Clin Pharm Ther


Mukai R,Hasegawa S,Umetsu R,Nakao S,Shimada K,Uranishi H,Masuta M,Suzuki H,Nishibata Y,Nakamura M




["FAERS","JADER","adverse event","fall","pregabalin"]


Has Abstract


2019-04-01 00:00:00












  • A phase I trial assessing the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of single-dose Auron Misheil therapy in healthy male subjects.

    abstract:BACKGROUND AND OBJECTIVE:Auron Misheil therapy (AMT) is a combination of widely used pharmaceuticals and herbal components that has been used since the 1980s as a supportive therapy, mainly in end-stage cancer patients on a compassionate basis. This phase I study was conducted to assess the safety, tolerability, and ph...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Scheele J,Diergarten K,Drevs J,Niazi FR

    更新日期:2013-02-01 00:00:00

  • Blood ribavirin concentration in high-dose ribavirin for adenovirus-induced haemorrhagic cystitis - a case report.

    abstract::Blood ribavirin concentration was monitored after the administration of high-dose oral ribavirin in a case of adenovirus-induced haemorrhagic cystitis post-stem-cell transplantation. Combination use of intravenous gamma immunoglobulin (15 g/3 days) and high-dose ribavirin (RBV; 9000 mg/4 days) provided plasma ribaviri...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Homma M,Inoue Y,Hasegawa Y,Kojima H,Kohda Y

    更新日期:2008-02-01 00:00:00

  • Factors limiting adherence to antiepileptic treatment: A French online patient survey.

    abstract:WHAT IS KNOWN AND OBJECTIVE:There are various reasons why antiepileptic treatment can fail. One is drug-resistant epilepsies, but non-adherence, or poor adherence, to treatment may make some patients' treatment ineffective. The consequences of poor adherence include treatment failure or introduction of more complex tre...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Laville F,Montana M,Roux N,Rathelot P,Giorgi R,Vanelle P

    更新日期:2018-02-01 00:00:00

  • Selecting outcome parameters in studies aimed at improving rational use of antibiotics - practical considerations.

    abstract::When designing studies of the optimal use of antimicrobial drugs, it is important to define at an early stage, which outcome parameters to use. It must be clear to which category a parameter to be measured belongs: the structure, the process or a clinical outcome. Attention must be paid to the measurement scales as we...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Natsch S,Kullberg BJ,Hekster YA,van der Meer JW

    更新日期:2003-12-01 00:00:00

  • Patient preferences for healthcare delivery through community pharmacy settings in the USA: A discrete choice study.

    abstract:WHAT IS KNOWN AND OBJECTIVE:In order to improve public health, it is necessary to facilitate patients' easy access to affordable high-quality primary health care, and one enhanced approach to do so may be to provide primary healthcare services in the community pharmacy setting. Discrete choice experiments to evaluate p...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Feehan M,Walsh M,Godin J,Sundwall D,Munger MA

    更新日期:2017-12-01 00:00:00

  • Throbbing headache associated with enoxaparin administration: a case report, a review of pharmacovigilance databases for similar cases and possible mechanisms.

    abstract:WHAT IS KNOWN AND OBJECTIVES:To date, no case of headache has been reported with enoxaparin. We present the case of a 60-years-old man, who developed enoxaparin-induced throbbing headache and discuss the possible pharmacological mechanisms. We provide an analysis of enoxaparin-induced headache in three international da...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Brusadelli T,Carnovale C,Gentili M,Borsadoli C,Speziali A,Perrone V,Pellegrino P,Antoniazzi S,Pozzi M,Radice S,Clementi E

    更新日期:2015-06-01 00:00:00

  • Radical scavenging activity of bisbenzylisoquinoline alkaloids and traditional prophylactics against chemotherapy-induced oral mucositis.

    abstract:BACKGROUND AND OBJECTIVE:Oral mucositis is a major severe toxic side-effect of systemic chemotherapy and irradiation in patients with cancer. Various free radical scavengers have been shown to prevent chemotherapy-induced skin necrosis. The objective of this study was to determine the antioxidant activity of a bisbenzy...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Kaji H,Inukai Y,Maiguma T,Ono H,Teshima D,Hiramoto K,Makino K

    更新日期:2009-04-01 00:00:00

  • Biosimilar infliximab in paediatric inflammatory bowel disease: Efficacy, immunogenicity and safety.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Based on extrapolation, biosimilar infliximab (IFX) was approved to treat inflammatory bowel disease (IBD). The first studies in adults have shown similar efficacy and safety in comparison with reference drug. The aim of this review was to collect and evaluate all the literature data regardi...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审


    authors: Dipasquale V,Romano C

    更新日期:2020-12-01 00:00:00

  • Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.

    abstract:WHAT IS KNOWN AND OBJECTIVE:The CHOP regimen with rituximab (R-CHOP) remains the standard for chemotherapy in patients with aggressive non-Hodgkin's lymphoma (NHL). The cardiotoxicity of doxorubicin appears to be a key problem in clinical practice. We studied the cardiotoxicity of CHOP/R-CHOP regimen in a retrospective...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Limat S,Daguindau E,Cahn JY,Nerich V,Brion A,Perrin S,Woronoff-Lemsi MC,Deconinck E

    更新日期:2014-04-01 00:00:00

  • Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Edoxaban has three dose adjustment factors (creatinine clearance, 15-50 mL/min; body weight, 60 kg or less; and concomitant medication with potent P-glycoprotein inhibitors) to prevent bleeding that results from elevated blood concentrations of the drug. A dose reduction (from 60 to 30 mg/da...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Takase T,Ikesue H,Nakagawa H,Kinoshita M,Muroi N,Kitai T,Furukawa Y,Hashida T

    更新日期:2020-04-01 00:00:00

  • Association of ABCB1 C3435T polymorphism with phenobarbital resistance in Thai patients with epilepsy.

    abstract:WHAT IS KNOWN AND OBJECTIVE:One-third of patients with epilepsy are resistant to anti-epileptic drugs (AEDs). Drug-resistant epilepsy is believed to be multifactorial involving both genetic and non-genetic factors. Genetic variations in the ABCB1 gene encoding the drug efflux transporter, p-glycoprotein (p-gp), may inf...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Keangpraphun T,Towanabut S,Chinvarun Y,Kijsanayotin P

    更新日期:2015-06-01 00:00:00

  • Baking soda misuse as a home remedy: case experience of the California Poison Control System.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Baking soda is a common household product promoted by the manufacturer as an antacid. It contains sodium bicarbonate and has the potential for significant toxicity when ingested in excessive amounts. Characterizing the patterns and outcomes from the misuse of baking soda as a home remedy can...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Al-Abri SA,Kearney T

    更新日期:2014-02-01 00:00:00

  • The influence of Rx-to-OTC changes on drug sales. Experiences from Sweden 1980-1994.

    abstract:OBJECTIVE:A descriptive study of national sales data from Sweden to find out the effect of over-the-counter (OTC) switches on total sales of a number of drugs. During the period 1980-94, 16 drugs were changed from prescription only (Rx) status to the Swedish OTC market. Total sales increased for 14 out of these 16 drug...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Carlsten A,Wennberg M,Bergendal L

    更新日期:1996-12-01 00:00:00

  • The use of prescription drugs among elderly Finnish men.

    abstract::The extent and factors that influence drug use were studied in two rural cohorts of Finnish men. The men aged between 65 and 84 years belonged to the Finnish study population of the 25-year follow-up of the 'Seven Countries Study'. Of the original 1,711 men in 1959, 766 were still alive in 1984. The participation rate...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Enlund H,Martikainen J,Turakka H,Nissinen A

    更新日期:1990-04-01 00:00:00

  • GPs' views on computerized drug interaction alerts: questionnaire survey.

    abstract:BACKGROUND:There is evidence that patients are being prescribed potentially hazardous drug-drug combinations in general practice despite the use of computerized drug interaction alert systems. One reason for this may be that general practitioners (GPs) are overriding these alerts without properly checking them. AIMS:(...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Magnus D,Rodgers S,Avery AJ

    更新日期:2002-10-01 00:00:00

  • A randomized phase I comparative pharmacokinetic study comparing SB5 with reference adalimumab in healthy volunteers.

    abstract:WHAT IS KNOWN AND OBJECTIVE:SB5 is a biosimilar to the reference adalimumab (ADL) currently in development. The primary study objective was to demonstrate pharmacokinetic (PK) equivalence of SB5 to European Union-sourced adalimumab (EU-ADL), and United States-sourced adalimumab (US-ADL) in healthy subjects. Safety, tol...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,随机对照试验


    authors: Shin D,Lee Y,Kim H,Körnicke T,Fuhr R

    更新日期:2017-12-01 00:00:00

  • Antiretroviral treatment leading to secondary trimethylaminuria: Genetic associations and successful management with riboflavin.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Trimethylaminuria is a metabolic disorder characterized by excessive excretion of trimethylamine in body fluids following FMO3 gene mutations. Secondary forms of the disease may be due to consumption of trimethylamine precursor-rich foods or metabolism of some xenobiotics. CASE SUMMARY:A HI...

    journal_title:Journal of clinical pharmacy and therapeutics



    authors: Scimone C,Alibrandi S,Donato L,Giofrè SV,Rao G,Sidoti A,D'Angelo R

    更新日期:2020-11-28 00:00:00

  • A Computer Prescribing Order Entry-Clinical Decision Support system designed for neonatal care: results of the 'preselected prescription' concept at the bedside.

    abstract:WHAT IS KNOWN:The neonatal intensive care units (NICUs) are at the highest risk of drug dose error of all hospital wards. NICUs also have the most complicated prescription modalities. The computerization of the prescription process is currently recommended to decrease the risk of preventable adverse drug effects (pADEs...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Gouyon B,Iacobelli S,Saliba E,Quantin C,Pignolet A,Jacqz-Aigrain E,Gouyon JB

    更新日期:2017-02-01 00:00:00

  • Investigation of urinary levels of salbutamol in asthmatic patients receiving inhaled therapy.

    abstract:AIM:Some studies have indicated that over-reliance on inhaled bronchodilator (beta 2-agonist) therapy may worsen asthma control and increase morbidity. The aim of this study was to measure urinary concentrations of salbutamol, the most commonly used bronchodilator, in a relatively large sample of asthmatic patients and...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Jacobson GA,Peterson GM,McLean S

    更新日期:1997-04-01 00:00:00

  • Therapeutic drug monitoring-based dose optimization for imatinib-associated serious cutaneous reactions in a patient with gastrointestinal stromal tumours: A case report.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Imatinib mesylate (IM) is the first-line therapy for unresectable or metastatic gastrointestinal stromal tumours (GISTs). Here, we report a case of successful progressive dose optimization by therapeutic drug monitoring (TDM) for a patient with GISTs who developed IM-associated serious cutan...

    journal_title:Journal of clinical pharmacy and therapeutics



    authors: Huang W,Li J,Qiu F,Wu X,Zhang J,Li X,Yao G,Zhu S

    更新日期:2020-08-01 00:00:00

  • A drug usage review of omeprazole.

    abstract::A drug use review of omeprazole was carried out at two centres in the Yorkshire Region from December 1990 to April 1991. Data collection documents were used and 66 patients in total were audited. Thirteen patients (19.7%) were treated for indications outside the product licence and 18 patients (27.3%) were treated for...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Norris CM,McManus PV,Petty D,Kay EA

    更新日期:1992-12-01 00:00:00

  • Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study.

    abstract::The efficacy of a novel, proprietary topical formulation of ibuprofen 5% gel (Ibugel) and ibuprofen 400 mg tablets (1200 mg daily) was compared in a double-blind, double-dummy, parallel group study in patients with acute soft tissue injuries. Patients received either active gel plus placebo tablets (n = 50) or active ...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 临床试验,杂志文章,随机对照试验


    authors: Whitefield M,O'Kane CJ,Anderson S

    更新日期:2002-12-01 00:00:00

  • G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation.

    abstract::Standard meta-analytical and pharmacoeconomic techniques were used to study the clinical effectiveness and the cost-effectiveness ratio of the prophylactic (or pre-emptive) administration of G-CSF to patients with small cell lung cancer treated with conventional myelosuppressive cytotoxic chemotherapy. In the first pa...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,meta分析


    authors: Messori A,Trippoli S,Tendi E

    更新日期:1996-04-01 00:00:00

  • Trends in pharmacists' medication order review in French hospitals from 2006 to 2009: analysis of pharmacists' interventions from the Act-IP© website observatory.

    abstract:WHAT IS KNOWN AND OBJECTIVES:The French Society of Clinical Pharmacy has developed a website, named Act-IP©, enabling hospital pharmacists to document and analyse pharmacists' interventions (PIs) proposed during medication order review when a drug-related problem is detected. This study analyses PIs documented in Act-I...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Bedouch P,Sylvoz N,Charpiat B,Juste M,Roubille R,Rose FX,Bosson JL,Conort O,Allenet B,French Society of Clinical Pharmacy's Act-IP© Group.

    更新日期:2015-02-01 00:00:00

  • Demonstrating effectiveness--the concept of numbers-needed-to-treat.

    abstract::When assessing a health-care intervention the main question is--does it work? Often, a more difficult question needs to be answered--how well does it work? Systematic reviews and meta-analyses help to provide answers to both questions. Too often though, the results are expressed in a way that leaves the reader asking,...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审


    authors: Wiffen PJ,Moore RA

    更新日期:1996-02-01 00:00:00

  • Population pharmacokinetics of ABT-594 in subjects with diabetic peripheral neuropathic pain.

    abstract:WHAT IS KNOWN AND OBJECTIVE:ABT-594 is a non-opioid, non-NSAID analgesic. The objective of this work was to characterize the population pharmacokinetics of ABT-594 in subjects with neuropathic pain. METHODS:Efficacy, safety and pharmacokinetics of ABT-594 in subjects with painful diabetic polyneuropathy were evaluated...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,多中心研究,随机对照试验


    authors: Dutta S,Awni W

    更新日期:2012-08-01 00:00:00

  • Prevalence of medication-related problems among patients with renal compromise in an Indian hospital.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Patients suffering from renal dysfunction often have multiple medical conditions either as a cause or as a consequence of their renal disease. These patients receive an average of 10-12 medications daily leading to complex dosing schedules and are more likely to develop medication-related pr...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Castelino RL,Sathvik BS,Parthasarathi G,Gurudev KC,Shetty MS,Narahari MG

    更新日期:2011-08-01 00:00:00

  • Population pharmacokinetic study of gentamicin and a Bayesian approach in patients with renal impairment.

    abstract::A population pharmacokinetic study was conducted on a total of 70 patients receiving gentamicin therapy. The patients included those with normal renal function and those with varying degrees of renal impairment. The parameters studied were the apparent volume of distribution and the plasma clearance of gentamicin. The...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Lanao JM,Berrocal A,Calvo MV,Perez M,de la Calle B,Domínguez-Gil A

    更新日期:1989-06-01 00:00:00

  • Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%).

    abstract:BACKGROUND AND OBJECTIVE:Moxifloxacin is a new fluorquinolone with broad-spectrum activity. It is suitable for treating peritonitis in peritoneal dialysis (PD) patients. The objective of this study was to test stability of moxifloxacin in PD solutions stored at different temperatures. METHODS:Dialysis solution bags we...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Fernández-Varón E,Marín P,Espuny A,Villamayor L,Escudero E,Cárceles C

    更新日期:2006-12-01 00:00:00

  • Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression.

    abstract:WHAT IS KNOWN AND OBJECTIVE:The current pharmacotherapeutic treatment of major depressive disorder (MDD) generally takes weeks to be effective. As the molecular action of these drugs is immediate, the mechanistic basis for this lag is unclear. A drug that has a more rapid onset of action would be a major therapeutic ad...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章


    authors: Drewniany E,Han J,Hancock C,Jones RL,Lim J,Nemat Gorgani N,Sperry JK 3rd,Yu HJ,Raffa RB

    更新日期:2015-04-01 00:00:00